Shaping the course of early-onset Parkinson's disease: insights from a longitudinal cohort.

Early-onset Parkinson’s disease Gender Hoehn and Yahr LEDD Motor fluctuations Progression Young-onset Parkinson’s disease

Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 22 09 2022
accepted: 20 04 2023
medline: 11 8 2023
pubmed: 4 5 2023
entrez: 4 5 2023
Statut: ppublish

Résumé

Early -onset Parkinson's disease (EOPD) labels those cases with onset earlier than fifty. Although peculiarities emerged either in clinical or pathological features, EOPD is managed alike typical, late-onset PD. A customized approach would be, instead, better appropriate. Accordingly, a deeper characterization of the clinical course, with an estimation of the disease progression rate, the therapy flow, and the main motor and non-motor complications occurrence, is needed. A longitudinal cohort of 193 EOPD patients (selected on a single-centre population of 2000 PD cases) was retrospectively analysed, providing descriptive statics on a series of clinical parameters (genetics, phenotype, comorbidities, therapies, motor and non-motor complications, marital and gender issues) and modelling the trajectories from diagnosis to 10 years later of both Hoehn and Yahr (H&Y) stage and levodopa equivalent daily dose (LEDD). EOPD had a prevalence of 9.7%, including few monogenic cases. It mostly appeared as a motor syndrome, with asymmetric, rigid-akinetic presentation. H&Y linearly progressed with an increment of 0.92 points/10 years; LEDD flow had a non-linear trend, increasing of 526.90 mg/day in 0-5 years, and 166.83 mg/day in 5-10 years. Motor fluctuations started 6.5 ± 3.2 years from onset, affecting up to 80% of the cohort. Neuropsychiatric troubles interested the 50%, sexual complaints the 12%. Gender-specific motor disturbances emerged. We shaped EOPD course, modelling a "brain-first" PD subtype, slowly progressive, with non-linear dopaminergic requirement. Major burden mostly resulted from motor fluctuations, neuropsychiatric complications, sexual and marital complaints, with a considerable gender-effect.

Identifiants

pubmed: 37140831
doi: 10.1007/s10072-023-06826-5
pii: 10.1007/s10072-023-06826-5
pmc: PMC10415517
doi:

Substances chimiques

Levodopa 46627O600J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3151-3159

Informations de copyright

© 2023. The Author(s).

Références

Parkinsonism Relat Disord. 2020 May;74:57-63
pubmed: 32335490
J Neurol. 2017 Aug;264(8):1583-1607
pubmed: 28054129
J Neurol Sci. 2016 Sep 15;368:150-4
pubmed: 27538621
NPJ Parkinsons Dis. 2018 Oct 2;4:31
pubmed: 30302392
Int J Geriatr Psychiatry. 2019 Aug;34(8):1128-1138
pubmed: 31069845
Mov Disord. 1986;1(1):85-7
pubmed: 3504235
Front Neurol. 2021 Sep 22;12:648588
pubmed: 34630269
J Neurol. 2021 May;268(5):1876-1884
pubmed: 33392638
Neurobiol Aging. 2020 Jun;90:119-124
pubmed: 32169356
Mov Disord. 2010 Apr 30;25(6):710-6
pubmed: 20213822
Mov Disord. 2013 Jul;28(8):1064-71
pubmed: 23630119
J Educ Eval Health Prof. 2013 Nov 30;10:12
pubmed: 24324853
PLoS One. 2020 Aug 20;15(8):e0237472
pubmed: 32817705
Parkinsonism Relat Disord. 2022 Sep;102:64-67
pubmed: 35963045
Parkinsonism Relat Disord. 2008;14(2):133-42
pubmed: 17804273
J Neurol. 2019 Aug;266(8):1944-1952
pubmed: 31076875
Neurology. 1991 Feb;41(2 ( Pt 1)):202-5
pubmed: 1992362
Mov Disord. 2003 Nov;18(11):1250-6
pubmed: 14639664
Mov Disord. 2015 Oct;30(12):1591-601
pubmed: 26474316
Parkinsonism Relat Disord. 2015 Aug;21(8):938-42
pubmed: 26071818
J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
pubmed: 1564476
Front Aging Neurosci. 2017 Dec 04;9:394
pubmed: 29255414
Parkinsonism Relat Disord. 2019 Aug;65:39-48
pubmed: 31176633
Mov Disord Clin Pract. 2022 Sep 10;9(7):869-878
pubmed: 36247919
Lancet Neurol. 2006 Apr;5(4):355-63
pubmed: 16545752
Neurology. 2009 Jul 21;73(3):206-12
pubmed: 19620608
Neuroimage Clin. 2019;21:101644
pubmed: 30584015
Neurobiol Dis. 2022 Mar;164:105626
pubmed: 35031485
Neurology. 1991 Feb;41(2 ( Pt 1)):168-73
pubmed: 1992358
Synapse. 2003 Feb;47(2):152-8
pubmed: 12454953
Eur J Neurol. 2009 Apr;16(4):450-6
pubmed: 19187262
Mov Disord Clin Pract. 2020 Mar 16;7(3):343-345
pubmed: 32258239
Parkinsonism Relat Disord. 2014 May;20(5):530-4
pubmed: 24631501
J Neural Transm (Vienna). 2021 Aug;128(8):1185-1193
pubmed: 34263354

Auteurs

Roberta Bovenzi (R)

Unit of Neurology, Department of Systems Medicine, University of Rome "Tor Vergata", Via Montpellier, 00133, Rome, Italy.

Matteo Conti (M)

Unit of Neurology, Department of Systems Medicine, University of Rome "Tor Vergata", Via Montpellier, 00133, Rome, Italy.

Giulia Rebecca Degoli (GR)

Unit of Neurology, Department of Systems Medicine, University of Rome "Tor Vergata", Via Montpellier, 00133, Rome, Italy.

Rocco Cerroni (R)

Unit of Neurology, Department of Systems Medicine, University of Rome "Tor Vergata", Via Montpellier, 00133, Rome, Italy.

Clara Simonetta (C)

Unit of Neurology, Department of Systems Medicine, University of Rome "Tor Vergata", Via Montpellier, 00133, Rome, Italy.

Claudio Liguori (C)

Unit of Neurology, Department of Systems Medicine, University of Rome "Tor Vergata", Via Montpellier, 00133, Rome, Italy.

Chiara Salimei (C)

Unit of Neurology, Department of Systems Medicine, University of Rome "Tor Vergata", Via Montpellier, 00133, Rome, Italy.

Antonio Pisani (A)

Department of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy.
IRCCS Mondino Foundation, Pavia, Italy.

Mariangela Pierantozzi (M)

Unit of Neurology, Department of Systems Medicine, University of Rome "Tor Vergata", Via Montpellier, 00133, Rome, Italy.

Alessandro Stefani (A)

Unit of Neurology, Department of Systems Medicine, University of Rome "Tor Vergata", Via Montpellier, 00133, Rome, Italy.
UOSD Parkinson Centre, Tor Vergata University Hospital, Rome, Italy.

Nicola Biagio Mercuri (NB)

Unit of Neurology, Department of Systems Medicine, University of Rome "Tor Vergata", Via Montpellier, 00133, Rome, Italy.
IRCCS Fondazione Santa Lucia, European Centre for Brain Research, Rome, Italy.

Tommaso Schirinzi (T)

Unit of Neurology, Department of Systems Medicine, University of Rome "Tor Vergata", Via Montpellier, 00133, Rome, Italy. t.schirinzi@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH